泰州市奶牛乳房炎调查及其病原菌的分离

奶牛乳房炎是奶牛场的常发病和难以防治的疾病,为进一步了解引起奶牛乳房炎的病原微生物,本研究通过对泰州市3个奶牛场572头泌乳牛的乳房炎发病率进行了调查并对乳房炎主要病原菌进行分离和鉴定。结果表明,奶牛临床型乳房炎的发病率为7.69%,隐性型乳房炎发病率为56.64%,乳区阳性率为33.8%,其中临床型:隐性=1:7.36。从65份确定患有乳房炎的奶样中共分离获得8种细菌、156株分离株,且引起乳房炎的主要病原菌是金黄色葡萄球菌和表皮葡萄球菌,其次是停乳链球菌、大肠杆菌、乳房链球菌和无乳链球菌,其检出率分别为42.31%、23.08%、8.97%、6.41%、5.13%和1.28%。该项调查结果初步明确了泰州市乳房炎发病情况,同时为进一步综合防治奶牛乳房炎和研制乳房炎治疗药物提供了科学依据。     

连翘有效成分提取及提取物对奶牛乳房炎致病菌的抑制效果

中药连翘具有抗菌、消炎、解热等作用,本研究目的在于摸索连翘有效成分提取的试验方法,获得适于抑制奶牛乳房炎致病菌的有效成分。以连翘叶片为材料,利用回流法提取工艺提取,采用薄层色谱（TLC）测定法定性分析,高效液相色谱法（HPLC）测定有效成分纯度,抑菌圈检测法检测抑菌效果。结果表明,连翘提取物对奶牛乳房炎致病菌具有抑制效果。     

临沂市奶牛乳房炎病原菌的分离鉴定与药敏试验

目的为弄清临沂市奶牛乳房炎主要病原菌种类及其药物敏感情况,为科学防治本病提供依据。方法采集患乳房炎奶牛的乳样进行细菌分离鉴定,并对主要病原菌做药敏试验。结果从115份乳样中,分离出6种127株病原菌,其中金黄色葡萄球菌46株,占36.22%,无乳链球菌33株,占25.98%,停乳链球菌21株,占16.53%,大肠埃希菌17株,占13.39%,乳房链球菌8株,占6.3%,沙门菌2株,占1.57%;主要病原菌均对头孢喹诺和左氧氟沙星高度敏感。结论临沂市奶牛乳房炎主要致病菌为金黄色葡萄球菌、链球菌和大肠埃希菌。首选药物为头孢喹诺和左氧氟沙星。因此,治疗奶牛乳房炎应通过药敏试验,合理地选择药物。     

奶牛乳房炎防治技术研究分析

奶牛乳房炎是奶牛的常见病之一,更是影响其养殖业发展、奶产品质量的重要原因。因此在奶牛的养殖中一定要从各个环境入手加强对奶牛乳房炎的防治。本文分析了奶牛乳房炎的发生原因及预防方法,为提升生产技术,保证奶产品的质量提供参考。     

奶牛乳房炎抗性候选基因的研究进展

乳房炎是奶业生产中的一种常见病,发病率很高,每年给世界各国奶牛饲养者造成严重的经济损失。乳房炎的影响因素很多,但遗传因素对其起着重要作用。综述了乳铁蛋白基因、MHC/BoLA基因、ToLL样受体家族基因、趋化性细胞因子受体基因、牛锌指蛋白313基因、β-防御素基因和热休克蛋白70基因等奶牛乳房炎抗性候选基因的研究现状。     

我国奶牛乳房炎致病性金黄色葡萄球菌血清型分布

本试验采用玻片凝集法对从临床型乳房炎病乳中分离获得的56株金黄色葡萄球菌进行血清型分型。结果表明336型占67.9%(38/56),5型占7.1%(4/56),8型占3.6%(2/56)。     

用转移因子治疗159例奶牛乳房炎的效果观察

本文报道了在国内首次用转移因子制剂治疗奶牛隐性乳房炎的效果。我们采用的转移因子制剂是本单位从健康猪脾细胞提取的,经按人用转移因子制检规程检测达到要求后,用于本省西部、东部和郊区三个奶牛场计159头患隐性乳房炎的奶牛,每天一次肌注,连续用药5次,测定用药前后的客观指标(CMT、BTB、苛性钠及氯化物凝乳试验等),以痊愈、显效、好转及无效等判定标准,经统计学处理后看出,用药后与用药前比较,差异非常显著(P<0.01),治疗组的有效率为91.2％,看出了应用转移因子治疗奶牛隐性乳房炎具有明显的治疗效果。     

新型奶牛乳房炎多联苗的研制及免疫力试验

目的：筛选出毒力较强的金黄色葡萄球菌、大肠杆菌、无乳链球菌作为制苗菌株,制成多联菌苗,预防及治疗奶牛乳房炎。方法：通过菌株的分离、纯化、鉴定试验及毒力试验获得毒力较强的菌株,制成金黄色葡萄球菌类毒素及菌体蛋白、大肠杆菌和无乳链球菌灭活菌苗,合理配伍制成多联菌苗,进行安全、异常毒性及免疫力试验。结果：所选金黄色葡萄球菌、大肠杆菌、无乳链球菌的最小致死量分别是3．0&#215;10^8／ml、1．5&#215;10^8／ml、9．0&#215;10^8／ml,多联苗安全、异常毒性试验合格,对免疫组小白鼠保护率为83．3％。结论：该多联菌苗具有安全、无毒、高效的特点,可以用来预防及治疗奶牛乳房炎。     

TNF-α基因多态性及其与奶牛乳房炎的相关性分析

以417头中国荷斯坦奶牛为研究对象,根据体细胞评分(Somatic cell score,SCS)的大小将该奶牛群体划分为感染牛群(100头)和健康牛群(317头)。通过PCR-RFLP和CRS-RFLP方法检测了肿瘤坏死因子α(Tumor necrosis factor-alpha,TNF-α)基因在荷斯坦奶牛群体中的多态性,并分析这些多态位点和奶牛乳房炎的相关性。研究发现了3个单核苷酸多态位点(Single-nucleotide polymorphism,SNP):第2外显子39bp处G→A的突变;第4外显子293bp处C→T的突变;5′侧翼区(5′-flanking region,5′UTR)C→G的突变。这3个突变位点分别是DraⅠ、AfaⅠ和DdeⅠ限制性内切酶的酶切多态位点,其中DraⅠ为创造酶切位点。经过基因型分析与χ2检验表明:3个酶切多态位点在荷斯坦奶牛群中均未达到Hardy-Weinberg平衡状态。运用SPSS13.0软件,采用最小二乘拟合线性模型分析3个酶切多态位点与SCS的关系,结果表明:AA基因型个体在DraⅠ酶切位点中的SCS显著大于BB及AB基因型个体(P0.05),BB基因型表现出乳房炎抗性。AfaⅠ酶切位点中BB基因型个体的SCS显著大于AA及AB基因型个体(P0.05),AA基因型表现出乳房炎抗性。DdeⅠ酶切位点中,AB基因型个体的SCS显著低于AA基因型个体(P0.05),AB基因型为优良基因型。因此BB、AA、AB基因型分别为DraⅠ、AfaⅠ、DdeⅠ酶切位点中的优良基因型,可作为分子标记应用于奶牛乳房炎抗性筛选。     

奶牛TLR4基因的多态性与乳房炎的相关性研究

TLR4通过识别病原体而激活免疫细胞,在先天免疫和适应性免疫防御中起着重要作用。以中国荷斯坦奶牛、三河牛和中国西门塔尔牛为研究对象,以TLR4为乳房炎抗性的候选基因,分别扩增316bp和382bp2个片段,分别采用SSCP和RFLP-AluⅠ方法来检测TLR4基因的多态性。结合测序发现:在intron1的第4,525bp处的A→G的突变,和exon3的第1,397bp处的T→C突变,使得产生多态。2个位点的A、B等位基因在3个群体中都有分布,且处于中度多态。χ2适合性检验表明,3个群体在这2个位点的突变达到Hardy-Weinberg平衡状态(P>0.05)。运用SAS8.0软件采用最小二乘法拟合线性模型,将基因座不同基因型与奶牛乳房炎进行了关联分析,结果表明:T4CRBR1的AA基因型为乳房炎抗性基因型(P<0.05),A等位基因为乳房炎抗性的有利基因,T4CRBR2的各基因型个体间的体细胞评分差异不显著(P>0.05)。     

Prevalence of antibiotic resistant mastitis pathogens in dairy cows in Egypt and potential biological control agents produced from plant endophytic actinobacteria

Dairy production is threatened by antibiotic resistant pathogens worldwide, and alternative solutions to treat mastitis are not available. The prevalence of antibiotic resistant strains is not well known in less developed countries. The prevalence of pathogenic bacteria and their resistance to 21 commercial antibiotics were studied in milk samples taken from 122 dairy cows suffering from the symptoms of mastitis in Egypt. The bacterial species were identified with molecular methods, and antibiotic resistance was studied with disc diffusion method. The prevalence of Streptococcus aureus, Escherichia coli and Pseudomonas aeruginosa were 30%, 17% and 3.5%, respectively. Most (90%) of the S. aureus strains showed resistance to penicillin whereas only 10% of the strains were resistant to oxacillin. Nearly half (40%) of E. coli strains showed resistance to streptomycin. Six P. aeruginosa strains showed resistance to several antibiotics, including ceftriaxone, enrofloxacin and levofloxacin. This points out that despite P. aeruginosa was not common, it should be followed up carefully. Potential biocontrol agents against antibiotic resistant mastitis bacteria were searched among 30 endophytic actinobacterial strains derived from wild medicinal plants. Three plants, namely Mentha longifolia, Malva parviflora and Pulicaria undulata were chosen for a more detailed study; their endophytic actinobacteria were used to prepare metabolic extracts. The crude metabolites of the actinobacteria were extracted with ethyl acetate. All metabolic extracts inhibited the growth of S. aureus, methicillin-resistant Staphylococcus aureus (MRSA), E. coli and P. aeruginosa in vitro. The 16S rRNA sequence analysis revealed that the most efficient actinobacterial strains were two Micromonospora sp. and one Actinobacteria bacterium. We conclude that the combination of the metabolites of several endophytic actinobacteria derived from several medicinal plants would be the most efficient against pathogens. Different metabolite cocktails should be studied further in order to develop novel biocontrol agents to treat antibiotic resistant mastitis bacteria in dairy cows.     

中草药复方对草鱼鱼种肠道菌群与血液有形成分的影响

目的探讨中草药复方对鱼种肠道菌群和血液有形成分的影响。方法以草鱼鱼种为动物模型,分别采用平板倾注法和ATB半自动化细菌鉴定法,测定投喂中草药复方药饵前、后鱼种肠道菌群数量及其优势菌群种类。同时使用常规计数法和改良沙利法,测定鱼种血液中红细胞、白细胞和血红蛋白的含量。结果对照组鱼种肠道内的细菌总数为6．6×10^8CFU／g,其优势菌群为气单胞菌、假单胞菌和肠杆菌;投喂2．5％、5．0％和7．5％中草药复方药饵10d后,其肠道内细菌总数均有所减少,分别为3．0×10^7CFU／g、5．0×10^6CFU／g和1．5×10^7CFU／g,其优势菌群为吲哚黄杆菌、产碱假单胞菌和野油菜黄单胞菌。实验组与对照组鱼种的红细胞数量差异无显著性,但白细胞与血红蛋白的含量差异有非常显著性（P〈0．01）。结论以黄连、大黄、金银花、连翘、黄芪和甘草组成的中草药复方对鱼种肠道菌群和血液有形成分均有一定影响,表现出该复方具有较好的免疫抗病作用。     

Pharmacological investigation of a HPLC/MS standardized three herbal extracts containing formulae (Bu-Shen-Yi-Qi-Tang) on airway inflammation and hypothalamic-pituitary-adrenal axis activity in asthmatic mice

Bu-Shen-Yi-Qi-Tang (BSYQT) which is prescribed on the basis of clinical experience is commonly used in clinic of traditional Chinese medicine (TCM) for asthma treatment. The components of BSYQT include Radix Astragali (RA), Herba Epimedii (HE) and Radix Rehmanniae (RR). The aim of this study was to screen extracts of BSYQT with best anti-inflammatory activity in asthmatic mice, and separate and identify the chemical compounds in them. Our results suggested that 60% ethanol extract of herbs (H60) and granules (G60) of BSYQT were the two extracts with best anti-inflammatory activity and effects of H60 were a little better than that of G60. High-performance liquid chromatography coupled to electrospray ionization and quadrupole time-of-flight mass spectrometry (HPLC–ESI-Q-TOF-MS/MS) analysis of the major chemical compounds of H60 and G60 revealed that 56 and 42 peaks were identified separately in H60 and G60. Further analysis revealed that 38 compounds were identified shared by H60 and G60, and 18 compounds were only in H60. There were 25 compounds in HE, 6 compounds in RR and 7 compounds in RA in the 38 compounds shared by G60 and H60. These 38 chemical components were tentatively considered the material basis of the anti-inflammatory activity of G60 and H60. The differences in the amount of the 38 chemical components as well as the 18 chemical components only in H60 were tentatively considered responsible for the activity differences between H60 and G60. In conclusion, these results suggested that extracts of BSYQT had inhibitory effects on airway inflammation in asthmatic mice, and H60 and G60 demonstrated the best anti-inflammatory activity. The 38 chemical compounds shared by H60 and G60 were responsible for their anti-inflammatory activity in asthmatic mice, and the differences in chemical compounds contents and amounts between H60 and G60 were responsible for this activity differences. This work would provide support for further pharmacodynamic material basis study of BSYQT.